A Study of RO4917838 (Bitopertin) in Patients With Acute Exacerbation of Schizophrenia

NCT01234779 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

301

Enrollment

INDUSTRY

Sponsor class

Conditions

Schizophrenia

Interventions

DRUG: bitopertin [RO4917838]
DRUG: bitopertin [RO4917838]
DRUG: olanzapine
DRUG: placebo

Sponsor

Hoffmann-La Roche